|
|||
|
DRUGS & SUPPLEMENTS
|
Cinnarizin Siegfried
What is the dose of the medication you are taking? |
Cinnarizin Siegfried uses
Pharmacological action
Cinnarizin Siegfried is a calcium channel blocker class IV with a predominant effect on the brain vessels, a derivative of piperazine. This medication improves cerebral, coronary and peripheral circulation. Cinnarizin Siegfried violates the entrance of calcium ions into vascular smooth muscle cells. This drug lowers the tone of arteriolar smooth muscle, decreases the vasoconstrictor response to biogenic substances. Cinnarizin Siegfried reduces the excitability of the vestibular apparatus. In patients with impaired peripheral circulation Cinnarizin Siegfried improves blood flow and potentiates postischemic hyperemia. This medicine increases the resistance of tissue to hypoxia.
Pharmacokinetics
After oral administration Cinnarizin Siegfried is absorbed from the gastrointestinal tract, Cmax in plasma is reached after 1-4 h. The plasma protein binding is 91%. This medication is metabolized. T1/2 is 3-6 hours. Cinnarizin Siegfried is eliminated through the intestine largely unchanged, with the urine - mainly in the form of metabolites.
Why is Cinnarizin Siegfried prescribed?
Ischemic attacks. Labyrinth disorders (including for maintenance therapy for dizziness, tinnitus, nystagmus, nausea and vomiting of labyrinth origin). Motion sickness (as a prophylactic agent). Prophylaxis of migraine. Meniere's disease. Prevention and treatment of disorders of peripheral circulation - atherosclerosis, thromboangiitis obliterans, Raynaud's disease, diabetic angiopathy, acrocyanosis.
Dosage and administration
The dosage regimen is individual. Cinnarizin Siegfried is taken orally in 25-50-75 mg 3 times / day after a meal. If necessary, the treatment can begin with half the dose and gradually increasing. To achieve the optimal therapeutic effect is used continuously for several months.
Cinnarizin Siegfried side effects, adverse reactions
Digestive system: dyspepsia, dry mouth, rarely - cholestatic jaundice.
CNS: headache, drowsiness; in elderly patients in long-term use may be extrapyramidal symptoms, depression.
Allergic reactions: rarely - skin rash.
Other: weight gain, increased sweating, in rare cases - lupus-like syndrome, lichen planus.
Cinnarizin Siegfried contraindications
Hypersensitivity to Cinnarizin Siegfried.
Using during pregnancy and breastfeeding
During pregnancy and lactation Cinnarizin Siegfried usage is possible only in exceptional cases, when the expected benefit to the mother far outweighs the potential risk to the fetus or infant.
Special instructions
Use Cinnarizin Siegfried with caution in patients with hypertension.
With prolonged use is recommended to perform control examination of liver, kidney, peripheral blood picture.
At the beginning of treatment you should refrain from potentially hazardous activities that require attention and speed of psychomotor reactions.
Cinnarizin Siegfried drug interactions
When this drug applied simultaneously with:
- tricyclic antidepressants, hypnotics, drugs that have a sedative effect, alcohol, ethanol-containing medication increases the effects on the CNS.
- antihypertensive drugs increased hypotensive effect.
- nootropics, vasodilators - increases the action of nootropic drugs and vasodilators.
- phenylpropanolamine reduces sedation effect of Cinnarizin Siegfried Quality Pharmaceutical Laboratory.
Cinnarizin Siegfried in case of emergency / overdose
Treatment: gastric lavage, taking activated charcoal, symptomatic therapy. There is no a specific antidote.
Cinnarizin Siegfried pharmaceutical active ingredients containing related brand and generic drugs:
Cinnarizin Siegfried available forms, composition, doses:
Cinnarizin Siegfried destination | category:
Cinnarizin Siegfried Anatomical Therapeutic Chemical codes:
Cinnarizin Siegfried pharmaceutical companies:
Frequently asked Questions
Can i drive or operate heavy machine after consuming Cinnarizin Siegfried?Depending on the reaction of the Cinnarizin Siegfried after taken, if you are feeling dizziness, drowsiness or any weakness as a reaction on your body, Then consider Cinnarizin Siegfried not safe to drive or operate heavy machine after consumption. Meaning that, do not drive or operate heavy duty machines after taking the capsule if the capsule has a strange reaction on your body like dizziness, drowsiness. As prescribed by a pharmacist, it is dangerous to take alcohol while taking medicines as it exposed patients to drowsiness and health risk. Please take note of such effect most especially when taking Primosa capsule. It's advisable to consult your doctor on time for a proper recommendation and medical consultations.
Is Cinnarizin Siegfried addictive or habit forming?Medicines are not designed with the mind of creating an addiction or abuse on the health of the users. Addictive Medicine is categorically called Controlled substances by the government. For instance, Schedule H or X in India and schedule II-V in the US are controlled substances.
Please consult the medicine instruction manual on how to use and ensure it is not a controlled substance.In conclusion, self medication is a killer to your health. Consult your doctor for a proper prescription, recommendation, and guidiance.
Review
sdrugs.com conducted a study on Cinnarizin Siegfried, and the result of the survey is set out below. It is noteworthy that the product of the survey is based on the perception and impressions of the visitors of the website as well as the views of Cinnarizin Siegfried consumers. We, as a result of this, advice that you do not base your therapeutic or medical decisions on this result, but rather consult your certified medical experts for their recommendations.Visitor reports
Visitor reported useful
No survey data has been collected yetVisitor reported side effects
No survey data has been collected yetVisitor reported price estimates
No survey data has been collected yetVisitor reported frequency of use
No survey data has been collected yetVisitor reported doses
No survey data has been collected yetVisitor reported time for results
No survey data has been collected yetVisitor reported administration
No survey data has been collected yetVisitor reported age
No survey data has been collected yetVisitor reviews
There are no reviews yet. Be the first to write one! |
The information was verified by Dr. Rachana Salvi, MD Pharmacology